MADISON, Wis. - A partnership on University of Wisconsin campuses will expand access and affordability of the life-saving opiate antidote Narcan, according to a release from Wisconsin Attorney General Brad Schimel.
Schimel’s office and UW System President Ray Cross, along with the drug’s manufacturer, Adapt Pharma Inc., announced the program, which is the first system-wide program that an educational institution has implemented, Wednesday, according to a release.
The program is an important step in educating students about the risks of opioid abuse, and will increase access to Narcan nasal spray, which is a ready-to-use, needle-free, high dose of naloxone that reverses the effects of an overdose, officials said.
"Earlier this year, DOJ partnered with Adapt Pharma to expand Narcan access in Wisconsin and once again we are partnering to extend Narcan’s reach even further," Schimel said in the release. "University of Wisconsin System President Cross is committed to the health and well-being of Wisconsin college students, and this new partnership will allow college campuses to have this potentially life-saving medication at the ready."
Officials said the program is aimed at keeping students and campuses safer.
Law enforcement officers and campus security at UW-Green Bay, UW-La Crosse, UW-Madison, UW-Oshkosh, UW-Platteville, UW-River Falls, UW-Stevens Point, UW-Stout and UW-Superior will be provided the nasal spray at no cost, according to the release.
Adapt Pharma says more than 216 colleges and universities in 35 states have participated in the program since it launched in April. The company has also worked with high schools and says it has distributed approximately 5,550 free doses to high schools in 41 states.
- Police: Wife shot in DeForest, husband in custody Friday night
- MSO concert reflects the gravity of the day
- Volunteers pack 120K meals to feed starving children
- Madison police rarely issue tickets for loud dogs
- Driver arrested after eluding officers, driving 100 mph, officials say
- Madison-made technology to treat diabetic foot ulcers